Worldwide prevalence of microbial agents' coinfection among COVID-19 patients: A comprehensive updated systematic review and meta-analysis.
Reza PakzadPooneh MalekifarZainab ShateriMilad ZandiSara Akhavan RezayatMaral SoleymaniMohammad Reza KarimiSeyed Esmaeil AhmadiRamin ShahbahramiIraj PakzadFatemeh AbdiAbbas FarahaniSaber SoltaniMina Mobini KeshehParastoo HosseiniPublished in: Journal of clinical laboratory analysis (2021)
We identified a high prevalence of pathogenic microorganism coinfection among COVID-19 patients. Because of this rate of coinfection empirical use of antibacterial, antifungal, and antiviral treatment are advisable specifically at the early stage of COVID-19 infection. We also suggest running simultaneously diagnostic tests to identify other microbiological agents' coinfection with SARS-CoV-2.